Jones Financial Companies’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2M Buy
33,070
+4,700
+17% +$197K ﹤0.01% 1577
2026
Q1
$851K Buy
28,370
+27,656
+3,873% +$1.02M ﹤0.01% 1789
2025
Q4
$30.1K Sell
714
-153
-18% -$6.17K ﹤0.01% 2757
2025
Q3
$29K Buy
867
+153
+21% +$4.39K ﹤0.01% 2612
2025
Q2
$19.5K Hold
714
– – ﹤0.01% 2600
2025
Q1
$21.5K Hold
714
– – ﹤0.01% 2401
2024
Q4
$28.3K Buy
714
+237
+50% +$8.97K ﹤0.01% 2106
2024
Q3
$16.1K Buy
+477
New +$13.4K ﹤0.01% 2033

Other funds holding VCYT

Jones Financial Companies's VCYT Position: Q2 2026 in Review

Jones Financial Companies increased its Veracyte (VCYT) stake by 17% in Q2 2026, buying an estimated $197K and bringing the position to 33,070 shares worth $2M. The position accounts for ﹤0.01% of the portfolio, ranked #1577.

Jones Financial Companies first reported a position in VCYT in Q3 2024 and has held it in 8 quarters since. 370 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.

  • Jones Financial Companies held 33,070 shares of Veracyte worth $2M as of Q2 2026.
  • Jones Financial Companies bought 4,700 Veracyte shares in Q2 2026, an estimated $197K.
  • Veracyte made up ﹤0.01% of Jones Financial Companies's portfolio in Q2 2026, its #1577 holding.
  • Jones Financial Companies first reported a position in Veracyte in Q3 2024 and has held it in 8 quarters since.
  • 370 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.